Jerusalem, Israel—October 15, 2020. Ex Libris, a ProQuest company, is pleased to announce that the Ex Libris Leganto course resource list solution and Ex Libris Esploro research information management solution are now included in the United States Federal Risk and Authorization Management Program (FedRAMP) and, under the sponsorship of the United States Department of Health and Human Services, have been added to the Ex Libris Authorization to Operate (ATO).
In September 2019, the Ex Libris Alma library services platform and Primo discovery solution achieved FedRAMP Tailored authorization, which is designed to support cloud solutions that are low risk. After successfully completing the annual FedRAMP evaluation in August 2020, the Leganto and Esploro solutions were added to the list of Ex Libris products that have fulfilled the strict security requirements for achieving a FedRAMP authorization. As a result, US government agencies can now expedite the procurement of Ex Libris cloud services. For more information, see the Ex Libris Trust Center.
"We are proud that both the Esploro and Leganto solutions have earned FedRAMP authorization and join our other products that have achieved this status," noted Barak Rozenblat, VP Cloud Services at Ex Libris. "The FedRAMP authorization demonstrates the US government's confidence in the security of our higher-ed cloud solutions and will facilitate the deployment of Ex Libris products by US agencies."
To view the Ex Libris listing in the FedRAMP Marketplace, click here.
About Ex Libris
Ex Libris, a ProQuest company, is a leading global provider of cloud-based SaaS solutions that enable institutions and their individual users to create, manage, and share knowledge. In close collaboration with its customers and the broader community, Ex Libris develops innovative solutions that increase library productivity, maximize the impact of research activities, enhance teaching and learning, and drive student mobile engagement. Ex Libris serves over 7,500 customers in 90 countries. For more information, see our website and join us on LinkedIn, YouTube, Facebook, and Twitter.